
    
      A randomized, open label, two treatment, two period, two sequence, single dose crossover,
      bioequivalence study of nabumetone 750 mg tablets of Dr. Reddy's Laboratories Limited and
      RelafenÂ® 750 mg tablets of Glaxosmithkline research triangle park, in healthy, adult, human
      subjects under fasting conditions.
    
  